Page last updated: 2024-10-24

protein localization to membrane raft

Definition

Target type: biologicalprocess

A process in which a protein is transported to, or maintained in, a location within a membrane raft. [GO_REF:0000087, GOC:dl, GOC:TermGenie, PMID:19414744]

Protein localization to membrane rafts is a complex process involving a series of interactions and modifications. Membrane rafts are specialized microdomains within the plasma membrane characterized by their enrichment in cholesterol, sphingolipids, and specific proteins. These domains act as platforms for signal transduction, cell adhesion, and other cellular processes.

The process of protein localization to membrane rafts can be broadly divided into three stages:

1. **Initial targeting:** Proteins can be targeted to membrane rafts through various mechanisms, including:
* **Lipid modifications:** Some proteins contain lipid modifications, such as palmitoylation or myristoylation, which can anchor them to the membrane. These modifications often target proteins to specific membrane domains, including rafts.
* **Protein-protein interactions:** Proteins can interact with other proteins that are already localized to rafts. These interactions can help to recruit the target protein to the raft domain.
* **Signal sequences:** Some proteins possess specific signal sequences that direct them to the membrane and potentially to rafts.

2. **Retention in rafts:** Once a protein reaches a raft, it can be retained through a variety of mechanisms:
* **Lipid interactions:** The protein may have a high affinity for the lipids that make up rafts, such as cholesterol and sphingolipids.
* **Protein-protein interactions:** The protein may interact with other raft-resident proteins, further stabilizing its localization within the domain.
* **Post-translational modifications:** Proteins may undergo modifications like palmitoylation or glycosylation, which can enhance their affinity for raft components.

3. **Dynamic regulation:** The localization of proteins to membrane rafts is not static and can be dynamically regulated by various factors, including:
* **Signal transduction:** Cells can respond to external stimuli by altering the composition and structure of membrane rafts. This can lead to the recruitment or removal of specific proteins from rafts.
* **Cellular trafficking:** Membrane rafts are not isolated compartments and can interact with other membrane domains, including endosomes and the Golgi apparatus. This dynamic interplay can influence the localization of proteins to rafts.

Overall, the process of protein localization to membrane rafts is a highly regulated and dynamic process that is essential for various cellular functions. It involves a complex interplay of lipid modifications, protein interactions, and signal transduction pathways that ensure the appropriate targeting and retention of proteins within these specialized membrane microdomains.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Cholesterol 24-hydroxylaseA cytochrome P450 46A1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y6A2]Homo sapiens (human)
Palmitoyltransferase ZDHHC2A palmitoyltransferase ZDHHC2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UIJ5]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
efavirenzefavirenz : 1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.

efavirenz: HIV-1 reverse transcriptase inhibitor
acetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound
antiviral drug;
HIV-1 reverse transcriptase inhibitor
cholesteryl sulfatecholesterol sulfate : A steroid sulfate that is cholesterol substituted by a sulfoxy group at position 3.

cholesteryl sulfate: component of human seminal plasma & spermatozoa; RN given refers to (3beta)-isomer
steroid sulfatehuman metabolite
voriconazolevoriconazole : A triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4.

Voriconazole: A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
conazole antifungal drug;
difluorobenzene;
pyrimidines;
tertiary alcohol;
triazole antifungal drug
P450 inhibitor
2-bromopalmitate2-bromohexadecanoic acid : A bromo fatty acid that is hexadecanoic (palmitic) acid carrying a single bromo substituent at position 2.

2-bromopalmitate: inhibitor of fatty acid oxidation; RN given refers to parent cpd
2-bromocarboxylic acid;
bromo fatty acid;
long-chain fatty acid;
straight-chain fatty acid
fatty acid oxidation inhibitor
pregnenolone sulfatepregnenolone sulfate: RN given refers to (3 beta)-isomersteroid sulfateEC 2.7.1.33 (pantothenate kinase) inhibitor;
human metabolite
8-hydroxyefavirenz
thioperamidethioperamide: structure given in first source; histamine H3 receptor antagonistprimary aliphatic amine